EXPOSURE VIA FATHER

This adverse event was reported 1305 times

EXPOSURE VIA FATHER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DIAZEPAM ORAL 185 0.0021
1 CLOMIPHENE CITRATE 3 0.0020
2 CHORIONIC GONADOTROPIN 1 0.0018
3 NILOTINIB 48 0.0016
4 DIAZEPAM 186 0.0015
5 ATOVAQUONE AND PROGUANIL HYDROCHLORIDE 3 0.0014
6 POTASSIUM BICARBONATE 1 0.0014
7 BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE 33 0.0014
8 FOLLITROPIN ALFA 2 0.0010
9 THIOGUANINE 2 0.0009
See all drugs enriched for association with EXPOSURE VIA FATHER

EXPOSURE VIA FATHER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 CD22-directed Immunoconjugate [EPC] 1 0.0003
2 Hedgehog Pathway Inhibitor [EPC] 3 0.0003
3 5-alpha Reductase Inhibitor [EPC] 30 0.0003
4 Nucleoside Analog Antiviral [EPC] 25 0.0003
5 Interferon beta [EPC] 56 0.0003
6 Pyrimidine Synthesis Inhibitor [EPC] 13 0.0003
7 Antimalarial [EPC] 3 0.0003
8 Antiprotozoal [EPC] 3 0.0003
9 Benzodiazepine [EPC] 193 0.0003
See all drug classes enriched for association with EXPOSURE VIA FATHER